Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,685,160
-$590,485 QoQ
Shares Held
27,447
-11.5% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#201
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $33,829,409 across 15 Diagnostics & Research names. LH ranks #2 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
16,090 | $8,066,882 | |
| 2 | LH |
Labcorp Holdings Inc.
This page
|
27,447 | $7,685,160 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
2,500 | $3,193,775 | |
| 4 | DHR |
Danaher Corp /De/
|
16,250 | $3,095,300 | |
| 5 | WAT |
Waters Corp /De/
|
7,877 | $2,954,190 | |
| 6 | GRAL |
GRAIL, Inc.
|
30,283 | $2,067,420 | |
| 7 | A |
Agilent Technologies, Inc.
|
13,309 | $1,767,834 | |
| 8 | NEO |
Neogenomics Inc
|
109,500 | $1,597,605 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,685,160 | 27,447 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $8,275,645 | 31,017 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,344,519 | 33,261 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $11,844,382 | 41,261 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $11,577,478 | 44,103 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,563,686 | 49,685 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,393,764 | 49,685 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $11,304,735 | 50,585 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,355,606 | 50,885 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||